Safety and persistence of WT1-specific T-cell receptor gene−transduced lymphocytes in patients with AML and MDS

Isao Tawara, Shinichi Kageyama, Yoshihiro Miyahara, +21

Blood

Ultra-low Dose Interleukin-2 Promotes Immune-modulating Function of Regulatory T Cells and Natural Killer Cells in Healthy Volunteers

Sawa Ito, Catherine M. Bollard, Mattias Carlsten, +19

Molecular Therapy

Healthy SubjectsAdaptive Immune SystemT-regulatory CellImmunologyImmune Regulation +22

Serum concentration of the soluble interleukin-2 receptor for monitoring acute graft-versus-host disease.

Taito Miyamoto, Kengo Akashi, Shin Hayashi, +5

PubMed

Gene-Modified Human α/β-T Cells Expressing a Chimeric CD16-CD3ζ Receptor as Adoptively Transferable Effector Cells for Anticancer Monoclonal Antibody Therapy

Fumihiro Ochi, Hiroshi Fujiwara, Kazushi Tanimoto, +9

Cancer Immunology Research

Absence of Chlamydial Infection in Japanese Patients with Ocular Adnexal Lymphoma of Mucosa-Associated Lymphoid Tissue

Yoshihiro Yakushijin, Toshio Kodama, Ikue Takaoka, +6

International Journal of Hematology

Lymphoid NeoplasiaOphthalmologyPathologyMedicineOcular Adnexal Lymphoma +2

A single-chain antibody generation system yielding CAR-T cells with superior antitumor function

Toshiki Ochi, Masaki Maruta, Kazushi Tanimoto, +7

Communications Biology

Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma

Koichi Nakase, Masamichi Hara, Teruhiko Kozuka, +2

Bone Marrow Transplantation

Radiation OncologyUnrelated DonorsTransplantationMarrow TransplantationAdult T-cell Leukaemia/lymphoma +7

Direct comparison of target-reactivity and cross-reactivity induced by CAR- and BiTE-redirected T cells for the development of antibody-based T-cell therapy

Masaki Maruta, Toshiki Ochi, Kazushi Tanimoto, +6

Scientific Reports

Human herpesvirus 6 infection impairs Toll-like receptor signaling

Yûichi Murakami, Kazushi Tanimoto, Hiroshi Fujiwara, +5

Virology Journal

Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia

Hiroki Tanaka, Hiroshi Fujiwara, Fumihiro Ochi, +9

Clinical Cancer Research